Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Kevin G. Friedman, M.D.

Co-Author

This page shows the publications co-authored by Kevin Friedman and Jane Newburger.
Connection Strength

7.071
  1. Cardiac Dysfunction in Multisystem Inflammatory Syndrome in Children: A Call to Action. J Am Coll Cardiol. 2020 10 27; 76(17):1962-1964.
    View in: PubMed
    Score: 0.951
  2. Primary adjunctive corticosteroid therapy is associated with improved outcomes for patients with Kawasaki disease with coronary artery aneurysms at diagnosis. Arch Dis Child. 2021 03; 106(3):247-252.
    View in: PubMed
    Score: 0.944
  3. Coronary Stenosis after Kawasaki Disease: Size Matters. J Pediatr. 2018 03; 194:8-10.
    View in: PubMed
    Score: 0.779
  4. Coronary Artery Aneurysms in Kawasaki Disease: Risk Factors for Progressive Disease and Adverse Cardiac Events in the US Population. J Am Heart Assoc. 2016 09 15; 5(9).
    View in: PubMed
    Score: 0.715
  5. Detailed Assessment of Left Ventricular Function in Multisystem Inflammatory Syndrome in Children Using Strain Analysis. CJC Open. 2021 Feb 25.
    View in: PubMed
    Score: 0.243
  6. Review of Cardiac Involvement in Multisystem Inflammatory Syndrome in Children. Circulation. 2021 01 05; 143(1):78-88.
    View in: PubMed
    Score: 0.238
  7. Regional Brain Growth Trajectories in Fetuses with Congenital Heart Disease. Ann Neurol. 2021 01; 89(1):143-157.
    View in: PubMed
    Score: 0.238
  8. Atrioventricular Block in Children With Multisystem Inflammatory Syndrome. Pediatrics. 2020 11; 146(5).
    View in: PubMed
    Score: 0.235
  9. Management of Myocardial Infarction in Children with Giant Coronary Artery Aneurysms after Kawasaki Disease. J Pediatr. 2020 06; 221:230-234.
    View in: PubMed
    Score: 0.229
  10. Fetal Aortic Valvuloplasty for Evolving Hypoplastic Left Heart Syndrome: A Decision Analysis. Circ Cardiovasc Qual Outcomes. 2020 04; 13(4):e006127.
    View in: PubMed
    Score: 0.229
  11. Impact of Socioeconomic Status on Outcomes of Patients with Kawasaki Disease. J Pediatr. 2019 09; 212:87-92.
    View in: PubMed
    Score: 0.216
  12. Risk Model Development and Validation for Prediction of Coronary Artery Aneurysms in Kawasaki Disease in a North American Population. J Am Heart Assoc. 2019 06 04; 8(11):e011319.
    View in: PubMed
    Score: 0.216
  13. Treatment Intensification in Patients With Kawasaki Disease and Coronary Aneurysm at Diagnosis. Pediatrics. 2019 06; 143(6).
    View in: PubMed
    Score: 0.214
  14. Association of Initially Normal Coronary Arteries With Normal Findings on Follow-up Echocardiography in Patients With Kawasaki Disease. JAMA Pediatr. 2018 12 01; 172(12):e183310.
    View in: PubMed
    Score: 0.208
  15. Safety and Efficacy of Warfarin Therapy in Kawasaki Disease. J Pediatr. 2017 10; 189:61-65.
    View in: PubMed
    Score: 0.187
  16. Coronary Artery Aneurysm Measurement and Z Score Variability in Kawasaki Disease. J Am Soc Echocardiogr. 2016 Feb; 29(2):150-7.
    View in: PubMed
    Score: 0.167
  17. Resource utilization after introduction of a standardized clinical assessment and management plan. Congenit Heart Dis. 2010 Jul-Aug; 5(4):374-81.
    View in: PubMed
    Score: 0.116
  18. Multisystem Inflammatory Syndrome in Children - Initial Therapy and Outcomes. N Engl J Med. 2021 07 01; 385(1):23-34.
    View in: PubMed
    Score: 0.062
  19. Cyclophosphamide use in treatment of refractory Kawasaki disease with coronary artery aneurysms. Pediatr Rheumatol Online J. 2021 Mar 17; 19(1):31.
    View in: PubMed
    Score: 0.061
  20. Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19. JAMA. 2021 03 16; 325(11):1074-1087.
    View in: PubMed
    Score: 0.061
  21. Socioeconomic and Racial and/or Ethnic Disparities in Multisystem Inflammatory Syndrome. Pediatrics. 2021 05; 147(5).
    View in: PubMed
    Score: 0.061
  22. Comparison Between Currently Recommended Long-Term Medical Management of Coronary Artery Aneurysms After Kawasaki Disease and Actual Reported Management in the Last Two Decades. Pediatr Cardiol. 2021 Mar; 42(3):676-684.
    View in: PubMed
    Score: 0.060
  23. Multiple Emergency Department Visits for a Diagnosis of Kawasaki Disease: An Examination of Risk Factors and Outcomes. J Pediatr. 2021 May; 232:127-132.e3.
    View in: PubMed
    Score: 0.060
  24. Distinct clinical and immunological features of SARS-CoV-2-induced multisystem inflammatory syndrome in children. J Clin Invest. 2020 11 02; 130(11):5942-5950.
    View in: PubMed
    Score: 0.060
  25. Cardiac manifestations in SARS-CoV-2-associated multisystem inflammatory syndrome in children: a comprehensive review and proposed clinical approach. Eur J Pediatr. 2021 Feb; 180(2):307-322.
    View in: PubMed
    Score: 0.059
  26. Medium-Term Complications Associated With Coronary Artery Aneurysms After Kawasaki Disease: A Study From the International Kawasaki Disease Registry. J Am Heart Assoc. 2020 08 04; 9(15):e016440.
    View in: PubMed
    Score: 0.058
  27. Association of Isolated Congenital Heart Disease with Fetal Brain Maturation. AJNR Am J Neuroradiol. 2020 08; 41(8):1525-1531.
    View in: PubMed
    Score: 0.058
  28. Low-Molecular-Weight Heparin vs Warfarin for Thromboprophylaxis in Children With Coronary Artery Aneurysms After Kawasaki Disease: A Pragmatic Registry Trial. Can J Cardiol. 2020 10; 36(10):1598-1607.
    View in: PubMed
    Score: 0.058
  29. Early-Emerging Sulcal Patterns Are Atypical in Fetuses with Congenital Heart Disease. Cereb Cortex. 2019 07 22; 29(8):3605-3616.
    View in: PubMed
    Score: 0.054
  30. Ascending Aorta Size at Birth Predicts White Matter Microstructure in Adolescents Who Underwent Fontan Palliation. J Am Heart Assoc. 2018 12 18; 7(24):e010395.
    View in: PubMed
    Score: 0.052
  31. Differentiating standardized clinical assessment and management plans from clinical practice guidelines. Acad Med. 2015 Aug; 90(8):1002.
    View in: PubMed
    Score: 0.041
  32. Prevalence of Undiagnosed Structural Heart Disease in Children Undergoing Echocardiography for Kawasaki Disease. Clin Pediatr (Phila). 2016 Jun; 55(6):557-9.
    View in: PubMed
    Score: 0.041
  33. Standardized Clinical Assessment And Management Plans (SCAMPs) provide a better alternative to clinical practice guidelines. Health Aff (Millwood). 2013 May; 32(5):911-20.
    View in: PubMed
    Score: 0.035
  34. Provider attitudes toward Standardized Clinical Assessment and Management Plans (SCAMPs). Congenit Heart Dis. 2011 Nov-Dec; 6(6):558-65.
    View in: PubMed
    Score: 0.032
  35. A novel approach to gathering and acting on relevant clinical information: SCAMPs. Congenit Heart Dis. 2010 Jul-Aug; 5(4):343-53.
    View in: PubMed
    Score: 0.029
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.